AGM/EGM11 Aug 2026, 08:30 pm
Zydus Lifesciences: Patel Reappointed MD, Lalbhai Appointed Independent Director
AI Summary
Zydus Lifesciences Ltd announced key management changes following its Thirty First Annual General Meeting held on August 11, 2026. Shareholders approved the re-appointment of Dr. Sharvil P. Patel as Managing Director for a further five-year term, effective April 1, 2027, to March 31, 2032. Additionally, Mr. Kulin S. Lalbhai has been appointed as an Independent Director for a term of five years, effective May 19, 2026, to May 18, 2031. These decisions were made pursuant to listing regulations and follow an earlier intimation dated May 19, 2026.
Key Highlights
- Dr. Sharvil P. Patel reappointed as MD for five years from April 2027.
- Mr. Kulin S. Lalbhai appointed as Independent Director for five years from May 2026.
- Decisions ratified at the Thirty First Annual General Meeting on August 11, 2026.
- Changes align with listing regulations and prior company disclosures.
Price Impact
More from ZYDUSLIFE